This information was current and correct as of the publish date.

A friend sent me this article this morning about Florida and the other states who were offering monoclonal antibody “clinics”. It says that they are changing the way they distribute Regeneron, as about 7 states are receiving the bulk of it. This might allow all of us in the States to have better access, as I have mentioned before, because some areas are reserving it for strictly emergency use. I feel we should keep asking our physicians to consider this as regular therapy for us, the immunocompromised, or at least for something like if you have to be in a large gathering situation or travel to a hot-zone like I was in last week while in Florida.

In the meantime, the United States federal government has worked out a deal to purchase more doses with an agreement that is good through the new year, “Under the new agreement, Regeneron will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022, at a cost of $2,100 per dose. This new agreement follows two earlier agreements with the U.S. government announced in July 2020 and January 2021.” I feel $2100 is a good amount to pay to save a life and at this time this treatment is still federally funded!

If you would like to check to see where monoclonal antibodies (like Regeneron) are being offered, Regeneron’s website has a link to the National Infusion Center locations. Remember, the FDA expanded the use of these antibodies in July, 2021. Many of our health providers are not aware of this and need to be made aware in order to refer you (if your state requires) for infusions.

Please refer to this resource that was published a few weeks ago and should still be fairly current.